Citation tools
"IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: study rationale and design." Stroke and Vascular Neurology
(2024):
svn-2024-003574.
Web. 04 May. 2025.